Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $28.63 USD
Change Today +1.28 / 4.68%
Volume 80.8K
LJPC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 12:25 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

la jolla pharmaceutical co (LJPC) Snapshot

Open
$27.35
Previous Close
$27.35
Day High
$29.23
Day Low
$27.28
52 Week High
07/6/15 - $29.23
52 Week Low
10/13/14 - $7.20
Market Cap
436.6M
Average Volume 10 Days
385.8K
EPS TTM
$-2.15
Shares Outstanding
15.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LA JOLLA PHARMACEUTICAL CO (LJPC)

la jolla pharmaceutical co (LJPC) Related Bloomberg News

View More Bloomberg News

la jolla pharmaceutical co (LJPC) Related Businessweek News

No Related Businessweek News Found

la jolla pharmaceutical co (LJPC) Details

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company engages in developing LJPC-501, an angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome; and GCS-100, a galectin-3 inhibitor for the potential treatment of chronic kidney disease. It also develops LJPC-1010 galectin-3 inhibitor for the potential treatment of nonalcoholic steatohepatitis and other diseases characterized by tissue fibrosis; and LJPC-401, a hepcidin for the potential treatment of hemochromatosis and beta thalassemia. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.

25 Employees
Last Reported Date: 03/16/15
Founded in 1989

la jolla pharmaceutical co (LJPC) Top Compensated Officers

Chief Executive Officer, President, Secretary...
Total Annual Compensation: $705.0K
Compensation as of Fiscal Year 2014.

la jolla pharmaceutical co (LJPC) Key Developments

La Jolla Pharmaceutical Co.(NasdaqCM:LJPC) added to Russell 2000 Index

La Jolla Pharmaceutical Co. will be added to Russell 2000 Index

La Jolla Pharmaceutical Co.(NasdaqCM:LJPC) added to Russell 3000 Index

La Jolla Pharmaceutical Co. will be added to the Russell 3000 Index.

La Jolla Pharmaceutical Co. Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 08:30 AM

La Jolla Pharmaceutical Co. Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 08:30 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: George F. Tidmarsh, Chief Executive Officer, President, Secretary and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LJPC:US $28.63 USD +1.28

LJPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,149 GBp -18.00
GlaxoSmithKline PLC 1,342 GBp -5.50
Merck & Co Inc $57.46 USD -0.21
Novartis AG SFr.92.95 CHF -0.10
Pfizer Inc $33.40 USD +0.025
View Industry Companies
 

Industry Analysis

LJPC

Industry Average

Valuation LJPC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 11.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LA JOLLA PHARMACEUTICAL CO, please visit www.lajollapharmaceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.